spacer
spacer
Go to PDB code: 
protein metals Protein-protein interface(s) links
Immune system PDB id
1osg
Jmol
Contents
Protein chains
(+ 0 more) 144 a.a. *
(+ 0 more) 12 a.a. *
Metals
_MG ×4
Waters ×20
* Residue conservation analysis
PDB id:
1osg
Name: Immune system
Title: Complex between baff and a br3 derived peptide presented in a beta-hairpin scaffold
Structure: Tumor necrosis factor ligand superfamily member 13b. Chain: a, b, c, d, e, f. Fragment: tnf domain. Synonym: tnf-and apol- related leukocyte expressed ligand 1, tall-1, b lymphocyte stimulator, blys, b cell- activating factor, baff, dendritic cell- derived tnf-like molecule. Engineered: yes.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: baff. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Other_details: this peptide was chemically synthesized.
Biol. unit: Hexamer (from PQS)
Resolution:
3.00Å     R-factor:   0.220     R-free:   0.286
Authors: N.C.Gordon,B.Pan,S.G.Hymowitz,J.P.Yin,R.F.Kelley, A.G.Cochran,M.Yan,V.M.Dixit,W.J.Fairbrother,M.A.Starovasnik
Key ref:
N.C.Gordon et al. (2003). BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry, 42, 5977-5983. PubMed id: 12755599 DOI: 10.1021/bi034017g
Date:
19-Mar-03     Release date:   27-May-03    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q9Y275  (TN13B_HUMAN) -  Tumor necrosis factor ligand superfamily member 13B
Seq:
Struc:
285 a.a.
144 a.a.
Protein chain
No UniProt id for this chain
Key:    PfamA domain  PfamB domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     membrane   1 term 
  Biological process     immune response   1 term 
  Biochemical function     tumor necrosis factor receptor binding     1 term  

 

 
DOI no: 10.1021/bi034017g Biochemistry 42:5977-5983 (2003)
PubMed id: 12755599  
 
 
BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
N.C.Gordon, B.Pan, S.G.Hymowitz, J.Yin, R.F.Kelley, A.G.Cochran, M.Yan, V.M.Dixit, W.J.Fairbrother, M.A.Starovasnik.
 
  ABSTRACT  
 
BAFF/BLyS, a member of the tumor necrosis family (TNF) superfamily of ligands, is a crucial survival factor for B cells. BAFF binds three receptors, TACI, BCMA, and BR3, with signaling through BR3 being essential for promoting B cell function. Typical TNF receptor (TNFR) family members bind their cognate ligands through interactions with two cysteine-rich domains (CRDs). However, the extracellular domain (ECD) of BR3 consists of only a partial CRD, with cysteine spacing distinct from other modules described previously. Herein, we report the solution structure of the BR3 ECD. A core region of only 19 residues adopts a stable structure in solution. The BR3 fold is analogous to the first half of a canonical TNFR CRD but is stabilized by an additional noncanonical disulfide bond. BAFF-binding determinants were identified by shotgun alanine-scanning mutagenesis of the BR3 ECD expressed on phage. Several of the key BAFF-binding residues are presented from a beta-turn that we have shown previously to be sufficient for ligand binding when transferred to a structured beta-hairpin scaffold [Kayagaki, N., Yan, M., Seshasayee, D., Wang, H., Lee, W., French, D. M., Grewal, I. S., Cochran, A. G., Gordon, N. C., Yin, J., Starovasnik, M. A, and Dixit, V. M. (2002) Immunity 10, 515-524]. Outside of the turn, mutagenesis identifies additional hydrophobic contacts that enhance the BAFF-BR3 interaction. The crystal structure of the minimal hairpin peptide, bhpBR3, in complex with BAFF reveals intimate packing of the six-residue BR3 turn into a cavity on the ligand surface. Thus, BR3 binds BAFF through a highly focused interaction site, unprecedented in the TNFR family.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20636329 E.Margolles-Clark, N.S.Kenyon, C.Ricordi, and P.Buchwald (2010).
Effective and specific inhibition of the CD40-CD154 costimulatory interaction by a naphthalenesulphonic acid derivative.
  Chem Biol Drug Des, 76, 305-313.  
20167627 W.Hugo, F.Song, Z.Aung, S.K.Ng, and W.K.Sung (2010).
SLiM on Diet: finding short linear motifs on domain interaction interfaces in Protein Data Bank.
  Bioinformatics, 26, 1036-1042.  
18512030 L.S.Treml, W.J.Quinn, J.F.Treml, J.L.Scholz, and M.P.Cancro (2008).
Manipulating B cell homeostasis: a key component in the advancement of targeted strategies.
  Arch Immunol Ther Exp (Warsz), 56, 153-164.  
18784835 M.R.Schmidt, M.C.Appel, L.J.Giassi, D.L.Greiner, L.D.Shultz, and R.T.Woodland (2008).
Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.
  PLoS ONE, 3, e3192.  
17449269 F.K.Chan (2007).
Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling.
  Cytokine, 37, 101-107.  
17150020 G.Fuh (2007).
Synthetic antibodies as therapeutics.
  Expert Opin Biol Ther, 7, 73-87.  
17500026 S.S.Sidhu, and A.A.Kossiakoff (2007).
Exploring and designing protein function with restricted diversity.
  Curr Opin Chem Biol, 11, 347-354.  
16914324 C.Bossen, and P.Schneider (2006).
BAFF, APRIL and their receptors: structure, function and signaling.
  Semin Immunol, 18, 263-275.  
16919470 L.S.Treml, J.E.Crowley, and M.P.Cancro (2006).
BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.
  Semin Immunol, 18, 297-304.  
17038469 M.P.Cancro (2006).
The BLyS/BAFF family of ligands and receptors: key targets in the therapy and understanding of autoimmunity.
  Ann Rheum Dis, 65, iii34-iii36.  
16474316 S.R.Dillon, J.A.Gross, S.M.Ansell, and A.J.Novak (2006).
An APRIL to remember: novel TNF ligands as therapeutic targets.
  Nat Rev Drug Discov, 5, 235-246.  
16370368 S.G.Hymowitz, and A.Ashkenazi (2005).
Toward small-molecule agonists of TNF receptors.
  Nat Chem Biol, 1, 353-354.  
15542592 S.G.Hymowitz, D.R.Patel, H.J.Wallweber, S.Runyon, M.Yan, J.Yin, S.K.Shriver, N.C.Gordon, B.Pan, N.J.Skelton, R.F.Kelley, and M.A.Starovasnik (2005).
Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding.
  J Biol Chem, 280, 7218-7227.
PDB codes: 1xu1 1xu2 1xut
14764606 D.R.Patel, H.J.Wallweber, J.Yin, S.K.Shriver, S.A.Marsters, N.C.Gordon, M.A.Starovasnik, and R.F.Kelley (2004).
Engineering an APRIL-specific B cell maturation antigen.
  J Biol Chem, 279, 16727-16735.  
15093829 G.Zhang (2004).
Tumor necrosis factor family ligand-receptor binding.
  Curr Opin Struct Biol, 14, 154-160.  
15546397 M.P.Cancro (2004).
The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation.
  Immunol Rev, 202, 237-249.  
12867412 A.L.Gavin, D.Aït-Azzouzene, C.F.Ware, and D.Nemazee (2003).
DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF.
  J Biol Chem, 278, 38220-38228.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.